Photo from Yuji Uehara/X
Dec 7, 2024, 16:57
Yuji Uehara: Milestones in Japan’s cancer registry projects
Yuji Uehara, Medical Oncologist, National Cancer Center, Japan, posted the following on X:
“Cancer registry (RWD) as external control data for regulatory submission in Japan:
- SCRUM-Japan: First regulatory approval for HER2+ colorectal cancer.
- MASTER KEY: Platform for rare cancers with 12 pharma partners.
- GALAXY: Large-scale DNA monitoring registry.
- REALISE: New initiative to standardize data quality (ARCAD global DB, SCRUM-Japan, and Flatiron Health RWD).”
Cancer registry as external control data for regulatory submission in Japan
Authors: H. Bando, N. Okita, Y. Sakamoto, H. Sokuoka, Y. Nakamura, T. Hashimoto, T. Misumi, Y. Takeda, Y. Aoyagi, K. Mizuguchi, H.S. Okuma, N. Fuse, K. Yonemori, K. Nakamura, N. Yamamoto, T. Yoshino, A. Ohtsu
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 7, 2024, 16:59
Dec 7, 2024, 16:59
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 16:57
Dec 7, 2024, 15:59
Dec 7, 2024, 15:17